PAVmed
PAVM
28 hedge funds and large institutions have $441K invested in PAVmed in 2025 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 6 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 4
9.24% less ownership
Funds ownership: 9.24% → 0% (-9.2%)
13% less funds holding
Funds holding: 32 → 28 (-4)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
85% less capital invested
Capital invested by funds: $2.95M → $441K (-$2.51M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$83.3K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$50.9K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$27.5K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$26K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$25.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SWGC
Summit Wealth Group (Colorado)
Colorado Springs,
Colorado
|
-$2.29M |
| 2 |
Jane Street
New York
|
-$65.6K |
| 3 |
VF
Virtu Financial
New York
|
-$17K |
| 4 |
OWP
Obermeyer Wealth Partners
Aspen,
Colorado
|
-$9.27K |
| 5 |
Carson Wealth (CWM LLC)
Omaha,
Nebraska
|
-$662 |
PAVM Hedge Fund Activity: Q4 2025 in Review
28 of the 8,280 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q4 2025, worth a combined $441K — down 85% from $2.95M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of PAVM and 3 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 8 added.
The largest buyer was UBS Group, adding an estimated $83.3K. The largest seller was Summit Wealth Group (Colorado), exiting entirely with an estimated $2.29M sold.
- 28 institutional investors held PAVmed (PAVM) as of Q4 2025, down from 32 in Q3 2025.
- Funds reported $441K of PAVmed stock for Q4 2025, down 85% quarter-over-quarter.
- 3 funds opened new PAVmed positions in Q4 2025 and 6 closed out, a net change of -3 holders.
- The largest PAVmed buyer in Q4 2025 was UBS Group, an estimated $83.3K added.
- The largest PAVmed seller in Q4 2025 was Summit Wealth Group (Colorado), an estimated $2.29M sold.
Based on aggregated 13F filings for Q4 2025.